Lingtao Jin

2.2k total citations
25 papers, 1.2k citations indexed

About

Lingtao Jin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lingtao Jin has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Lingtao Jin's work include Cancer, Hypoxia, and Metabolism (6 papers), Melanoma and MAPK Pathways (3 papers) and RNA modifications and cancer (3 papers). Lingtao Jin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Melanoma and MAPK Pathways (3 papers) and RNA modifications and cancer (3 papers). Lingtao Jin collaborates with scholars based in United States, China and France. Lingtao Jin's co-authors include Sumin Kang, Gina N. Alesi, Kelly R. Magliocca, Fadlo R. Khuri, Jaemoo Chun, Yibin Kang, Dong M. Shin, Chaoyun Pan, Chunlian Pan and Taofeek K. Owonikoko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lingtao Jin

24 papers receiving 1.2k citations

Peers

Countries citing papers authored by Lingtao Jin

Since Specialization

Citations

This map shows the geographic impact of Lingtao Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingtao Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingtao Jin more than expected).

Fields of papers citing papers by Lingtao Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingtao Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingtao Jin. The network helps show where Lingtao Jin may publish in the future.

Co-authorship network of co-authors of Lingtao Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Lingtao Jin. A scholar is included among the top collaborators of Lingtao Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingtao Jin. Lingtao Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine 2024 ·Lung Cancer ·Josephine A. Taverna, (unknown), (unknown), Ryan A. Williams, (unknown), (unknown), Vaishnavi Sambandam, (unknown), Paweł A. Osmulski, Maria Gaczyńska, Daniel T. DeArmond, (unknown), Maria Mancini, (unknown), (unknown), Lina Song, Lingtao Jin, (unknown), Chun‐Liang Chen	13
2	RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity 2023 ·Molecular Cell ·Fang Yu, Allen Zhu, Shun Liu, Boyang Gao, Yuzhi Wang, (unknown), Chunjie Yu, Qiong Wu, (unknown), Jikui Song, Lingtao Jin, Chuan He, Zhijian Qian	31
3	Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice 2023 ·Cell Death Discovery ·Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, J Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine L. Hann, Maria Zajac‐Kaye, Frederic J. Kaye, Daohong Zhou	31
4	ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1 2023 ·iScience ·(unknown), Ravi N. Padia, Mahmuda Akter, Lei Sun, Bin Li, (unknown), Jianhui Guo, Zheng Qing Fu, Lingtao Jin, Shuang Huang	14
5	ROS-mediated SRMS activation confers platinum resistance in ovarian cancer 2023 ·Oncogene ·(unknown), Lina Song, Yizhu Lin, (unknown), Qiongmei Gao, Tao Li, Bin Li, Xiaobo Mao, Qianqian Song, Chengguo Xing, Guangrong Zheng, Shuang Huang, Lingtao Jin	9
6	Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis 2023 ·Proceedings of the National Academy of Sciences ·Austin C. Boese, JiHoon Kang, Jung Seok Hwang, Jae Hyun Kim, Kiyoung Eun, (unknown), Kelly R. Magliocca, Chaoyun Pan, Lingtao Jin, Sumin Kang	19
7	FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts 2022 ·Cancer Gene Therapy ·Bin Li, (unknown), (unknown), Yue Li, Tao Li, Lingtao Jin, Shuang Huang	9
8	EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer 2022 ·Cell Reports ·JiHoon Kang, Jaemoo Chun, Jung Seok Hwang, Chaoyun Pan, Jie Li, Austin C. Boese, (unknown), (unknown), Yibin Kang, Don L. Gibbons, Gabriel Sica, Haian Fu, Suresh S. Ramalingam, Lingtao Jin, Sumin Kang	22
9	LKB1 phosphorylation and deactivation in lung cancer by NNAL, a metabolite of tobacco-specific carcinogen, in an isomer-dependent manner 2022 ·Oncogene ·Tengfei Bian, Yuzhi Wang, (unknown), Qi Hu, (unknown), Adriana Zingone, (unknown), Yougen Wu, (unknown), Ramzi G. Salloum, Graham Warren, Zhiguang Huo, Bríd M. Ryan, Lingtao Jin, Chengguo Xing	10
10	Attenuated miR-203b-3p is critical for ovarian cancer progression and aptamer/miR-203b-3p chimera can be explored as a therapeutic 2022 ·SHILAP Revista de lepidopterología ·Tao Li, Yue Li, (unknown), (unknown), Ravi N. Padia, (unknown), (unknown), (unknown), Lingtao Jin, Shuang Huang	5
11	Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1 2021 ·npj Breast Cancer ·Haoming Chen, Ravi N. Padia, Tao Li, Yue Li, Bin Li, Lingtao Jin, Shuang Huang	6
12	Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer 2020 ·Signal Transduction and Targeted Therapy ·(unknown), Yue Li, Tao Li, Ravi N. Padia, (unknown), Lingtao Jin, Huijun Chen, Shuang Huang	24
13	Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation 2019 ·Journal of Clinical Investigation ·Chaoyun Pan, Jaemoo Chun, Dan Li, Austin C. Boese, Jie Li, JiHoon Kang, (unknown), (unknown), Lina Song, Kelly R. Magliocca, Zhuo G. Chen, Nabil F. Saba, (unknown), Taofeek K. Owonikoko, Sagar Lonial, Lingtao Jin, Sumin Kang	32
14	Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance 2019 ·Journal of Clinical Investigation ·Chaoyun Pan, Lingtao Jin, Xu Wang, Yuancheng Li, Jaemoo Chun, Austin C. Boese, Dan Li, Hee‐Bum Kang, Guojing Zhang, Lu Zhou, Georgia Z. Chen, Nabil F. Saba, (unknown), Kelly R. Magliocca, Taofeek K. Owonikoko, Hui Mao, Sagar Lonial, Sumin Kang	31
15	Abstract 1454: Glutamate dehydrogenase 1 mediates metabolic reprogramming and promotes tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer 2018 ·Cancer Research ·Sumin Kang, Lingtao Jin, Chaoyun Pan, Jaemoo Chun	0
16	The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer 2017 ·Molecular Cell ·Lingtao Jin, Jaemoo Chun, Chaoyun Pan, Avi Kumar, Guojing Zhang, (unknown), Dan Li, Gina N. Alesi, Yibin Kang, Lu Zhou, Wen-Mei Yu, Kelly R. Magliocca, Fadlo R. Khuri, Cheng‐Kui Qu, Christian M. Metallo, Taofeek K. Owonikoko, Sumin Kang	230
17	Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis 2017 ·Oncogene ·Lingtao Jin, Jaemoo Chun, Chunlian Pan, Gina N. Alesi, (unknown), Kelly R. Magliocca, Yibin Kang, (unknown), Dong M. Shin, Fadlo R. Khuri, Jun Fan, Sumin Kang	201
18	RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis 2016 ·Oncogene ·Gina N. Alesi, Lingtao Jin, (unknown), Kelly R. Magliocca, Yibin Kang, (unknown), Dong M. Shin, Fadlo R. Khuri, Sumin Kang	27
19	The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote Tumor Metastasis 2013 ·Journal of Biological Chemistry ·Dan Li, Lingtao Jin, Gina N. Alesi, Youngmee Kim, Jun Fan, Jae Ho Seo, Dongsheng Wang, Meghan Tucker, Ting-Lei Gu, Benjamin H. Lee, Jack Taunton, Kelly R. Magliocca, Zhuo G. Chen, Dong M. Shin, Fadlo R. Khuri, Sumin Kang	44
20	p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms 2013 ·Molecular and Cellular Biology ·Lingtao Jin, Dan Li, Jong Seok Lee, Shannon Elf, Gina N. Alesi, Jun Fan, Hee‐Bum Kang, Dongsheng Wang, Haian Fu, Jack Taunton, Titus J. Boggon, Meghan Tucker, Ting‐Lei Gu, Zhuo G. Chen, Dong M. Shin, Fadlo R. Khuri, Sumin Kang	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact